Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPC-expanded cord blood in hematologic malignancies
NCT01854567Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Aug 2013
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
A Phase 3 trial of mesenchymal precursor cell-expanded cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Mesoblast Ltd. Started Aug 2013; status: completed.
02
Drugs
mesenchymal precursor cell-expanded cord blood
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01854567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854567.